Global Viral Vector CDMO Services Market Growth (Status and Outlook) 2025-2031

Report ID: 3035999 | Published Date: Dec 2025 | No. of Page: 215 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025

The global Viral Vector CDMO Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.

CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.

CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.

Segmentation by Type:

  • AAV
  • Lentivirus
  • Adenovirus
  • HSV
  • Others

Segmentation by Application:

  • Vaccine Development
  • Gene Therapy
  • Academic Scientific Research Institution
  • Others

Market by Region:

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Key Companies:

  • Thermo Fisher Scientific
  • Lonza
  • Catalent
  • Charles River
  • Merck
  • SK pharmteco
  • Oxford Biomedica
  • AGC Biologics（MolMed）
  • Gene Universal
  • Polyplus (Sartorius)
  • CCRM
  • FUJIFILM Diosynth Biotechnologies
  • Biovian
  • Miltenyi Bioindustry
  • Aldevron
  • Takara Bio
  • Yposkesi
  • Genezen
  • GenScript ProBio
  • EurekaBio
  • Obio Technology
  • GeneSail Biotech
  • VectorBuilder
  • WuXi ATU
  • Ubrigene
  • Porton Biologics
  • Pharmaron
  • PackGene Biotechnology
  • Hillgene
  • Asymchem
  • Exthera
  • Flash Therapeutics
  • VIVEBiotech
  • FinVector
  • uBriGene
  • Eurogentec
  • VGXI

Key Questions Addressed in this Report
Frequently Asked Questions
Viral Vector CDMO Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Vector CDMO Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Vector CDMO Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports